Post-approval studies (Phase 4)UnknownNCT05039580
What this trial is testing
Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy
Who this might be right for
EBV Infection
The First Affiliated Hospital of Soochow University 36